Market Cap 1.69B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 5,491,944
Avg Vol 7,443,908
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 56%
Beta 1.18
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Ckkung71
Ckkung71 Jun. 22 at 8:46 PM
$ABCL Strong today
0 · Reply
Joshkatz96
Joshkatz96 Jun. 22 at 8:01 PM
$ABCL love that idiot @tradersunion353 who constantly spams here - closed green again today and is in accumulation mode. love it!
1 · Reply
Money_maker777
Money_maker777 Jun. 22 at 8:00 PM
$ABCL We closed green today, and with this momentum building, I think this week is shaping up to be a good one.
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 7:55 PM
$ABCL This is daily drama.. pay to paid pumpers.. overhype the junk stock performance is peanuts.. what a POS for last 5 years what did this POS acheive --- Nothing in terms of stock price.
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 7:10 PM
$ABCL A stock that refuses to go down in a weak market is a stock under accumulation.” - Richard Wyckoff. The accumulation has been going on since February...slow and steady!
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 7:06 PM
$ABCL Biotech M&A and parternships haven’t been this active and strong in a very long time. The best stocks will go parabolic. My bet is $ABCL as the most disruptive company in the sector. Remember, this is 20 years in the making. Founder is a top G supervillain.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 6:57 PM
$ABCL All eyes on Carl tomorrow huge biotech week this week!! He might just drop the new molecule at the conference as all eyes are on him and toast all the shorts in the process. 😉👀
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 22 at 6:44 PM
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 22 at 6:16 PM
$ABCL even Bruins legend is on this ticker lets go… but buyout $50 a share. 10 years $7B annual revenue and 15x PE $350 a share
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 5:53 PM
$ABCL lets see if this pos will stay green by the closing time enough of fooling real longs here
2 · Reply
Latest News on ABCL
AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 17 days ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 5 weeks ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 6 weeks ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 7 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 7 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 2 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 4 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 5 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 8 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 10 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 10 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 10 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 11 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Ckkung71
Ckkung71 Jun. 22 at 8:46 PM
$ABCL Strong today
0 · Reply
Joshkatz96
Joshkatz96 Jun. 22 at 8:01 PM
$ABCL love that idiot @tradersunion353 who constantly spams here - closed green again today and is in accumulation mode. love it!
1 · Reply
Money_maker777
Money_maker777 Jun. 22 at 8:00 PM
$ABCL We closed green today, and with this momentum building, I think this week is shaping up to be a good one.
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 7:55 PM
$ABCL This is daily drama.. pay to paid pumpers.. overhype the junk stock performance is peanuts.. what a POS for last 5 years what did this POS acheive --- Nothing in terms of stock price.
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 7:10 PM
$ABCL A stock that refuses to go down in a weak market is a stock under accumulation.” - Richard Wyckoff. The accumulation has been going on since February...slow and steady!
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 7:06 PM
$ABCL Biotech M&A and parternships haven’t been this active and strong in a very long time. The best stocks will go parabolic. My bet is $ABCL as the most disruptive company in the sector. Remember, this is 20 years in the making. Founder is a top G supervillain.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 6:57 PM
$ABCL All eyes on Carl tomorrow huge biotech week this week!! He might just drop the new molecule at the conference as all eyes are on him and toast all the shorts in the process. 😉👀
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 22 at 6:44 PM
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 22 at 6:16 PM
$ABCL even Bruins legend is on this ticker lets go… but buyout $50 a share. 10 years $7B annual revenue and 15x PE $350 a share
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 5:53 PM
$ABCL lets see if this pos will stay green by the closing time enough of fooling real longs here
2 · Reply
Biotechsleuth
Biotechsleuth Jun. 22 at 4:24 PM
$ABCL scam run by grifters with federal funds!
0 · Reply
PattyBergeron
PattyBergeron Jun. 22 at 4:09 PM
$ABCL i feel like in ten years this will trade 20-35x its current price.
2 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 22 at 3:48 PM
$ABCL Bears worst nightmare
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 2:50 PM
$ABCL Paid clowns are pumping this scam everyday on X. But this is not even moving few cents ... Don't fall for paid pumpers.
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 2:16 PM
$ABCL Business as usual POS will go red and close red Instead of company overhyping how about deliver some value to shareholders??
1 · Reply
bonecrack_benny
bonecrack_benny Jun. 22 at 2:08 PM
$ABCL massive week and month in front of us
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jun. 22 at 2:03 PM
$ABCL Game time, buy buy buy
0 · Reply
TradeWinner
TradeWinner Jun. 22 at 1:58 PM
$ABCL New 52 weeks high soon. Shorts will 🔥!!
0 · Reply
Kaykay610
Kaykay610 Jun. 22 at 1:15 PM
$ABCL based on the apogee therapeutics buyout so is the ox40 pathway dead or alive? Abcellera has some things to figure out
1 · Reply
Estimize
Estimize Jun. 22 at 11:03 AM
Wall St is expecting -0.14 EPS for $ABCL Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/abcl?chart=historical&metric_name=eps&utm_c
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 22 at 10:58 AM
$ABCL Biotech M&A Just the start in my opinion, $ABBV is closing in on a nearly $11B cash deal to buy Apogee Therapeutics, per FT. The discussed deal would value $APGE at $10.9B, roughly a 60% premium to Thursday’s close, and could be announced as soon as Today. Apogee’s lead drug, zumilokibart, is being developed as a longer-acting alternative to Dupixent, with dosing studied every 3 to 6 months vs. Dupixent’s every 2 weeks. Apogee plans to start a Phase 3 trial in atopic dermatitis later this year.
0 · Reply
tradersunion353
tradersunion353 Jun. 22 at 10:50 AM
$ABCL overhyped underperforming junk badly wants to open and close Red demamp and other paid clowns pumping isnt working .,
1 · Reply